Insud Pharma   Report issue

For profit Phase 1 Phase 3
Founded: Madrid Spain (1940)

Organization Overview

First Clinical Trial
2013
NCT02268045
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Chemo | Chemo France | Exeltis USA, Inc. | Insud Pharma | Laboratories Leon Farma, S.A. | mAbxience S.A